These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 11228507)

  • 21. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women.
    Andrews WW; Sibai BM; Thom EA; Dudley D; Ernest JM; McNellis D; Leveno KJ; Wapner R; Moawad A; O'Sullivan MJ; Caritis SN; Iams JD; Langer O; Miodovnik M; Dombrowski M;
    Obstet Gynecol; 2003 May; 101(5 Pt 1):847-55. PubMed ID: 12738139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical length and quantitative fetal fibronectin in the prediction of spontaneous preterm birth in asymptomatic women with congenital uterine anomaly.
    Ridout AE; Ibeto LA; Ross GN; Cook JR; Sykes L; David AL; Seed PT; Tribe RM; Bennett PR; Terzidou V; Shennan AH; Chandiramani M; ; Brown RG; Chatfield S; Sadeh D
    Am J Obstet Gynecol; 2019 Oct; 221(4):341.e1-341.e9. PubMed ID: 31132343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor.
    Schmitz T; Maillard F; Bessard-Bacquaert S; Kayem G; Fulla Y; Cabrol D; Goffinet F
    Am J Obstet Gynecol; 2006 Jan; 194(1):138-43. PubMed ID: 16389023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth.
    Goldenberg RL; Iams JD; Mercer BM; Meis PJ; Moawad A; Das A; Miodovnik M; Vandorsten PJ; Caritis SN; Thurnau G; Dombrowski MP;
    Am J Obstet Gynecol; 2001 Sep; 185(3):643-51. PubMed ID: 11568793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative fetal fibronectin and cervical length to predict preterm birth in asymptomatic women with previous cervical surgery.
    Vandermolen BI; Hezelgrave NL; Smout EM; Abbott DS; Seed PT; Shennan AH
    Am J Obstet Gynecol; 2016 Oct; 215(4):480.e1-480.e10. PubMed ID: 27267388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth.
    Hezelgrave NL; Kuhrt K; Cottam K; Seed PT; Tribe RM; Shennan AH
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():103-108. PubMed ID: 27918947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk.
    Abbott DS; Hezelgrave NL; Seed PT; Norman JE; David AL; Bennett PR; Girling JC; Chandirimani M; Stock SJ; Carter J; Cate R; Kurtzman J; Tribe RM; Shennan AH
    Obstet Gynecol; 2015 May; 125(5):1168-1176. PubMed ID: 25932845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network.
    Goldenberg RL; Mercer BM; Meis PJ; Copper RL; Das A; McNellis D
    Obstet Gynecol; 1996 May; 87(5 Pt 1):643-8. PubMed ID: 8677060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.
    Liong S; Di Quinzio MK; Fleming G; Permezel M; Rice GE; Georgiou HM
    BJOG; 2015 Feb; 122(3):370-9. PubMed ID: 25056135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth.
    Kurkinen-Räty M; Ruokonen A; Vuopala S; Koskela M; Rutanen EM; Kärkkäinen T; Jouppila P
    BJOG; 2001 Aug; 108(8):875-81. PubMed ID: 11510716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth.
    Owen J; Yost N; Berghella V; Thom E; Swain M; Dildy GA; Miodovnik M; Langer O; Sibai B; McNellis D;
    JAMA; 2001 Sep; 286(11):1340-8. PubMed ID: 11560539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal fetal fibronectin measurements from 8 to 22 weeks' gestation and subsequent spontaneous preterm birth.
    Goldenberg RL; Klebanoff M; Carey JC; Macpherson C; Leveno KJ; Moawad AH; Sibai B; Heine RP; Ernest JM; Dombrowski MP; Miodovnik M; Wapner RJ; Iams JD; Langer O; O'sullivan MJ; Roberts JM
    Am J Obstet Gynecol; 2000 Aug; 183(2):469-75. PubMed ID: 10942489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth-weight infants.
    Bartnicki J; Casal D; Kreaden US; Saling E; Vetter K
    Am J Obstet Gynecol; 1996 Mar; 174(3):971-4. PubMed ID: 8633678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal fibronectin in patients at increased risk for premature birth.
    Nageotte MP; Casal D; Senyei AE
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):20-5. PubMed ID: 8296822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personalized assessment of cervical length improves prediction of spontaneous preterm birth: a standard and a percentile calculator.
    Gudicha DW; Romero R; Kabiri D; Hernandez-Andrade E; Pacora P; Erez O; Kusanovic JP; Jung E; Paredes C; Berry SM; Yeo L; Hassan SS; Hsu CD; Tarca AL
    Am J Obstet Gynecol; 2021 Mar; 224(3):288.e1-288.e17. PubMed ID: 32918893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population.
    Greenhagen JB; Van Wagoner J; Dudley D; Hunter C; Mitchell M; Logsdon V; Casal D; Varner M
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):1054-6. PubMed ID: 8885775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
    Berghella V; Saccone G
    Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network.
    Goldenberg RL; Iams JD; Mercer BM; Meis PJ; Moawad AH; Copper RL; Das A; Thom E; Johnson F; McNellis D; Miodovnik M; Van Dorsten JP; Caritis SN; Thurnau GR; Bottoms SF
    Am J Public Health; 1998 Feb; 88(2):233-8. PubMed ID: 9491013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women.
    Esplin MS; Elovitz MA; Iams JD; Parker CB; Wapner RJ; Grobman WA; Simhan HN; Wing DA; Haas DM; Silver RM; Hoffman MK; Peaceman AM; Caritis SN; Parry S; Wadhwa P; Foroud T; Mercer BM; Hunter SM; Saade GR; Reddy UM;
    JAMA; 2017 Mar; 317(10):1047-1056. PubMed ID: 28291893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.